who owns tirzepatide The FDA has approved another obesity pill, called Foundayo, from pharmaceutical maker Eli Lilly.⁠ ⁠ Although Eli Lilly is the same company behind Zepbound, the blockbuster injectable obesity medicine, the company decided FDA approves new weight loss

It is now the "incumbent" defending against Lilly's clinical superiority and facing pricing pressure and patent expirations in major international markets

Injections can also cause injection-site reactions

Available in-clinic or on-site (home or office) when appropriate

Wegovy was also recently approved to treat noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis in adults

Some pharmacokinetic studies have examined the lower end of the dose-response curve, but these were conducted to establish appropriate starting doses for titration, not to validate microdosing as a standalone strategy